Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−77.31 MXN
−10.45 B MXN
1.46 B MXN
87.31 M
About Vir Biotechnology, Inc.
Sector
Industry
CEO
Marianne de Backer
Website
Headquarters
San Francisco
Founded
2016
FIGI
Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The firm's technology platforms include antibody, T cell, innate immunity and siRNA, which are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. The company was founded by Robert Taylor Nelsen, Klaus Frueh, Jay Parrish, Lawrence Corey, and Louis Picker in April 7, 2016 and is headquartered in San Francisco, CA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on BIVA exchange VIR BIOTECHNOLOGY, INC stocks are traded under the ticker VIR.
VIR stock has risen by 5.32% compared to the previous week, the month change is a 5.32% rise, over the last year VIR BIOTECHNOLOGY, INC has showed a 5.32% increase.
We've gathered analysts' opinions on VIR BIOTECHNOLOGY, INC future price: according to them, VIR price has a max estimate of 2,224.65 MXN and a min estimate of 202.24 MXN. Watch VIR chart and read a more detailed VIR BIOTECHNOLOGY, INC stock forecast: see what analysts think of VIR BIOTECHNOLOGY, INC and suggest that you do with its stocks.
VIR stock is 5.32% volatile and has beta coefficient of 0.72. Track VIR BIOTECHNOLOGY, INC stock price on the chart and check out the list of the most volatile stocks — is VIR BIOTECHNOLOGY, INC there?
Today VIR BIOTECHNOLOGY, INC has the market capitalization of 22.31 B, it has decreased by −29.22% over the last week.
Yes, you can track VIR BIOTECHNOLOGY, INC financials in yearly and quarterly reports right on TradingView.
VIR BIOTECHNOLOGY, INC is going to release the next earnings report on Feb 20, 2025. Keep track of upcoming events with our Earnings Calendar.
VIR earnings for the last quarter are −30.74 MXN per share, whereas the estimation was −20.74 MXN resulting in a −48.22% surprise. The estimated earnings for the next quarter are −17.98 MXN per share. See more details about VIR BIOTECHNOLOGY, INC earnings.
VIR BIOTECHNOLOGY, INC revenue for the last quarter amounts to 46.89 M MXN, despite the estimated figure of 109.17 M MXN. In the next quarter, revenue is expected to reach 168.30 M MXN.
VIR net income for the last quarter is −4.21 B MXN, while the quarter before that showed −2.54 B MXN of net income which accounts for −65.91% change. Track more VIR BIOTECHNOLOGY, INC financial stats to get the full picture.
No, VIR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 28, 2024, the company has 587.00 employees. See our rating of the largest employees — is VIR BIOTECHNOLOGY, INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VIR BIOTECHNOLOGY, INC EBITDA is −10.34 B MXN, and current EBITDA margin is −744.43%. See more stats in VIR BIOTECHNOLOGY, INC financial statements.
Like other stocks, VIR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VIR BIOTECHNOLOGY, INC stock right from TradingView charts — choose your broker and connect to your account.